HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sai-Juan Chen Selected Research

Lasers (Laser)

4/2008PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.
6/2007[Expression of tumor suppressor gene PRDM1 in lung cancers].
10/2006[BCL-XL expression and mutation in non-Hodgkin's lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sai-Juan Chen Research Topics

Disease

35Neoplasms (Cancer)
12/2023 - 11/2002
33Leukemia
01/2022 - 02/2002
29Acute Promyelocytic Leukemia
01/2021 - 02/2002
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 12/2003
12BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2024 - 12/2004
12Lymphoma (Lymphomas)
10/2023 - 10/2006
8Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 05/2005
7Multiple Myeloma
04/2024 - 02/2012
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 07/2007
4Genetic Translocation (Chromosomal Translocation)
01/2022 - 11/2002
4Graves Disease (Basedow Disease)
01/2019 - 08/2011
3Inflammation (Inflammations)
10/2021 - 05/2015
3Myeloid Leukemia (Leukemia, Myelocytic)
01/2019 - 08/2012
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023 - 01/2020
2Thalassemia
11/2021 - 02/2009
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2021 - 01/2021
2Hemorrhage
11/2019 - 04/2018
2Cardiotoxicity
06/2019 - 07/2009
2Carcinogenesis
04/2018 - 06/2015
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2018 - 05/2006
2Lung Neoplasms (Lung Cancer)
06/2015 - 06/2007
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2015 - 02/2013
2Hyperthyroidism
08/2013 - 08/2011
2Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2012 - 07/2008
2Blast Crisis (Blast Phase)
03/2012 - 05/2006
2Body Weight (Weight, Body)
07/2009 - 04/2007
1Cytokine Release Syndrome
01/2024
1Infections
01/2023
1Neutropenia
01/2023
1Febrile Neutropenia
01/2023
1Pharyngitis (Sore Throat)
11/2021
1Fever (Fevers)
11/2021
1Fatigue
11/2021
1Exanthema (Rash)
11/2021
1Dizziness (Lightheadedness)
11/2021
1Hemophilia B (Haemophilia B)
10/2021

Drug/Important Bio-Agent (IBA)

21Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 02/2002
19Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2003
14Arsenic Trioxide (Trisenox)FDA Link
01/2021 - 02/2002
10ArsenicIBA
04/2024 - 01/2005
8Imatinib Mesylate (Gleevec)FDA Link
04/2024 - 12/2004
7Chimeric Antigen ReceptorsIBA
04/2024 - 01/2019
6Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2004
5DNA (Deoxyribonucleic Acid)IBA
11/2021 - 06/2007
5MethyltransferasesIBA
01/2020 - 02/2010
5Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019 - 01/2005
5Oncogene Proteins (Oncogene Protein)IBA
03/2012 - 12/2004
4B-Cell Maturation AntigenIBA
04/2024 - 01/2019
4Arsenicals (Arsenic Compounds)IBA
04/2024 - 11/2002
4Rituximab (Mabthera)FDA Link
01/2023 - 07/2007
4Therapeutic UsesIBA
02/2013 - 05/2005
4Retinoic Acid Receptor alphaIBA
03/2008 - 02/2002
3AntigensIBA
12/2023 - 08/2013
3RNA (Ribonucleic Acid)IBA
10/2023 - 01/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 06/2011
3Lysine (L-Lysine)FDA Link
01/2020 - 02/2010
3Histones (Histone)IBA
01/2020 - 02/2010
3Bortezomib (Velcade)FDA Link
11/2015 - 01/2011
3Biomarkers (Surrogate Marker)IBA
12/2013 - 06/2007
3Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
08/2013 - 06/2011
3Tyrosine Kinase InhibitorsIBA
02/2012 - 01/2007
3Proteasome InhibitorsIBA
01/2011 - 04/2008
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
04/2024 - 12/2023
2CytokinesIBA
01/2024 - 02/2014
2GlobinsIBA
11/2021 - 02/2009
2EnzymesIBA
11/2019 - 01/2014
2AnthracyclinesIBA
06/2019 - 01/2019
2Long-Acting Thyroid Stimulator (LATS)IBA
01/2019 - 08/2011
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2017 - 08/2008
2Glucose (Dextrose)FDA LinkGeneric
11/2016 - 09/2014
2DNA Methyltransferase 3AIBA
02/2014 - 01/2013
2alpha-hydroxyglutarateIBA
12/2013 - 10/2013
2realgar-indigo naturalisIBA
11/2013 - 03/2008
2eriocalyxin BIBA
02/2013 - 03/2010
2oridoninIBA
03/2012 - 04/2007
2bcr-abl Fusion ProteinsIBA
03/2012 - 02/2005
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2012 - 12/2010
2Cell Adhesion Molecule-1IBA
06/2011 - 01/2011
2Monoclonal AntibodiesIBA
06/2011 - 12/2007
2Phosphotransferases (Kinase)IBA
03/2010 - 01/2007
2Positive Regulatory Domain I-Binding Factor 1IBA
07/2007 - 06/2007
2promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
01/2007 - 11/2002
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2007 - 02/2005
2Aligeron (AS 2)IBA
04/2004 - 11/2002
1Single-Domain AntibodiesIBA
12/2023
1ChemokinesIBA
11/2023
1GATA2 Transcription FactorIBA
01/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023
1Prednisone (Sone)FDA LinkGeneric
01/2023
1Vincristine (Oncovin)FDA LinkGeneric
01/2023
1Co-Repressor ProteinsIBA
01/2022
1Thalidomide (Thalomid)FDA Link
11/2021
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2021
1Blood Coagulation Factors (Coagulation Factor)IBA
10/2021
1Small Cytoplasmic RNAIBA
10/2021
1Cysteine (L-Cysteine)FDA Link
01/2021

Therapy/Procedure

28Therapeutics
01/2024 - 05/2002
6Drug Therapy (Chemotherapy)
01/2023 - 05/2005
3Lasers (Laser)
04/2008 - 10/2006
1Aftercare (After-Treatment)
04/2024